NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OutSee

OutSee

Private
CambridgeEnterprise Softwarehttps://www.outsee.co.uk/

Last Round

Grant

May 19, 2026

Total Funding Raised

$4.21M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OutSee is a biotechnology company that develops and applies innovative computational approaches to genomics for drug target discovery and precision medicine.

Sector

Enterprise Software

Verticals

Retail Technology, Digital Advertising

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

digital signagepredictive genomicscontent management softwaredrug discoveryprecision medicinevisual communicationgenomics aidigital displaystarget discoverypatient stratificationmanaged signagebioinformaticsdigital signage softwareai drug discoveryretail technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OutSee Comparables

Compare OutSee with similar companies based on industry and business-model similarity.

OutSee comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

OutSee Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 19, 2026
SeedJan 12, 2026
GrantJun 24, 2025

Key People

Founding team and executive leadership

Julian Gough

Chief Executive Officer

Executive Team

James Peach

Chief Operating Officer

Executive Team

OutSee Investors

Notable investors and investment history

OutSee investors
InvestorRounds
Innovate UKGrant
Empirical VenturesSeed
Ahren Innovation CapitalSeed, Grant
Empirical VenturesSeed, Grant
Kadmos CapitalSeed, Grant
Panacea Venture HealthcareSeed, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Developing lead drug target candidate with o2h discovery.

  • Jan 20, 2026

    Partnered with o2h discovery to develop a lead drug target candidate.

OutSee Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OutSee Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OutSee's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range10
Year Founded2022
Last FundingMay 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.